Hall P - Search Results

1

One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net Benefit.

McCabe C, Paulden M, Awotwe I, Sutton A, Hall P. McCabe C, et al. Among authors: hall p. Pharmacoeconomics. 2020 Feb;38(2):135-141. doi: 10.1007/s40273-019-00869-3. Pharmacoeconomics. 2020. PMID: 31840216 Free PMC article.

2

Cost analysis for cancer subgroups.

Hall PS, Rautenberg TA, McCabe C. Hall PS, et al. Br J Cancer. 2009 May 5;100(9):1513. doi: 10.1038/sj.bjc.6605035. Br J Cancer. 2009. PMID: 19401705 Free PMC article. No abstract available.

3

Health economics in drug development: efficient research to inform healthcare funding decisions.

Hall PS, McCabe C, Brown JM, Cameron DA. Hall PS, et al. Eur J Cancer. 2010 Oct;46(15):2674-80. doi: 10.1016/j.ejca.2010.06.122. Epub 2010 Jul 23. Eur J Cancer. 2010. PMID: 20655197 Free article.

4

Updated cost-effectiveness analysis of trastuzumab for early breast cancer: a UK perspective considering duration of benefit, long-term toxicity and pattern of recurrence.

Hall PS, Hulme C, McCabe C, Oluboyede Y, Round J, Cameron DA. Hall PS, et al. Pharmacoeconomics. 2011 May;29(5):415-32. doi: 10.2165/11588340-000000000-00000. Pharmacoeconomics. 2011. PMID: 21504241

5

Economic evaluation of genomic test-directed chemotherapy for early-stage lymph node-positive breast cancer.

Hall PS, McCabe C, Stein RC, Cameron D. Hall PS, et al. J Natl Cancer Inst. 2012 Jan 4;104(1):56-66. doi: 10.1093/jnci/djr484. Epub 2011 Dec 2. J Natl Cancer Inst. 2012. PMID: 22138097 Free article.

6

Expected net present value of sample information: from burden to investment.

Hall PS, Edlin R, Kharroubi S, Gregory W, McCabe C. Hall PS, et al. Med Decis Making. 2012 May-Jun;32(3):E11-21. doi: 10.1177/0272989X12443010. Epub 2012 Apr 30. Med Decis Making. 2012. PMID: 22546749 Free article.

7

What evidence is there for the reimbursement of personalised medicine?

Hall PS, McCabe C. Hall PS, et al. Pharmacoeconomics. 2013 Mar;31(3):181-3. doi: 10.1007/s40273-013-0025-x. Pharmacoeconomics. 2013. PMID: 23436473 No abstract available.

8

Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others.

Bartlett JM, Bayani J, Marshall A, Dunn JA, Campbell A, Cunningham C, Sobol MS, Hall PS, Poole CJ, Cameron DA, Earl HM, Rea DW, Macpherson IR, Canney P, Francis A, McCabe C, Pinder SE, Hughes-Davies L, Makris A, Stein RC; OPTIMA TMG. Bartlett JM, et al. Among authors: hall ps. J Natl Cancer Inst. 2016 Apr 29;108(9):djw050. doi: 10.1093/jnci/djw050. Print 2016 Sep. J Natl Cancer Inst. 2016. PMID: 27130929 Free PMC article. Clinical Trial.

9

Cost-effectiveness analysis of PET-CT-guided management for locally advanced head and neck cancer.

Smith AF, Hall PS, Hulme CT, Dunn JA, McConkey CC, Rahman JK, McCabe C, Mehanna H. Smith AF, et al. Among authors: hall ps. Eur J Cancer. 2017 Nov;85:6-14. doi: 10.1016/j.ejca.2017.07.054. Epub 2017 Sep 4. Eur J Cancer. 2017. PMID: 28881249 Free article. Clinical Trial.

10

Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim Trial.

Hall PS, Smith A, Hulme C, Vargas-Palacios A, Makris A, Hughes-Davies L, Dunn JA, Bartlett JMS, Cameron DA, Marshall A, Campbell A, Macpherson IR, Dan Rea, Francis A, Earl H, Morgan A, Stein RC, McCabe C; OPTIMA Trial Management Group. Hall PS, et al. Value Health. 2017 Dec;20(10):1311-1318. doi: 10.1016/j.jval.2017.04.021. Epub 2017 Jul 11. Value Health. 2017. PMID: 29241890 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,645 results

Search Page

Filters